| Charles P Catania, MD | |
|
1240 Wrights Ln, West Chester, PA 19380-4252 | |
| (610) 431-1210 | |
| (610) 594-2625 |
| Full Name | Charles P Catania |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 1240 Wrights Ln, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609037027 | NPI | - | NPPES |
| 1028528620001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD449497 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
| Bayada Home Health Care, Inc. | Exton, PA | Home health agency |
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Willow Tree Hospice | Kennett square, PA | Hospice |
| Chester County Hospital | West chester, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pentahealth, Llc | 9537586672 | 59 |
News Archive
The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.
Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.
Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).
Bacterial infections can strike anyone, and they can sometimes be fatal. Because more and more bacteria are becoming resistant to the pre-eminent remedy - antibiotics - the search for new remedies against bacterial infections is in high gear.
› Verified 9 days ago
| Entity Name | Gateway Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770659476 PECOS PAC ID: 5294707634 Enrollment ID: O20040806001106 |
News Archive
The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.
Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.
Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).
Bacterial infections can strike anyone, and they can sometimes be fatal. Because more and more bacteria are becoming resistant to the pre-eminent remedy - antibiotics - the search for new remedies against bacterial infections is in high gear.
› Verified 9 days ago
| Entity Name | Pentahealth, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639787740 PECOS PAC ID: 9537586672 Enrollment ID: O20200903000805 |
News Archive
The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.
Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.
Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).
Bacterial infections can strike anyone, and they can sometimes be fatal. Because more and more bacteria are becoming resistant to the pre-eminent remedy - antibiotics - the search for new remedies against bacterial infections is in high gear.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles P Catania, MD 412 Creamery Way, Suite 400, Exton, PA 19341-2551 Ph: (610) 594-7590 | Charles P Catania, MD 1240 Wrights Ln, West Chester, PA 19380-4252 Ph: (610) 431-1210 |
News Archive
The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.
Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits - both inpatient and emergency - and lower the risk for atrial fibrillation, according to research by UC San Francisco.
Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).
Bacterial infections can strike anyone, and they can sometimes be fatal. Because more and more bacteria are becoming resistant to the pre-eminent remedy - antibiotics - the search for new remedies against bacterial infections is in high gear.
› Verified 9 days ago
Dr. Paul Debacco, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1161 Mcdermott Dr., Suite 101, West Chester, PA 19380 Phone: 610-701-7011 Fax: 610-429-5199 | |
Miss Sara Elizabeth Sterling, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 Fax: 610-431-5025 | |
Levelle Drose-bigatel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Mcdaniel Dr, Suite 50, West Chester, PA 19380 Phone: 484-905-8000 Fax: 484-905-8005 | |
Dr. George Nicholas Spyropoulos, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1646 W Chester Pike, Suite 12, West Chester, PA 19382 Phone: 610-738-9002 Fax: 610-738-9101 | |
Dr. Louis H Hirshberg, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1114 Lincoln Dr, West Chester, PA 19380 Phone: 610-608-4051 | |
Mary Brigandi, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Marshall St, West Chester, PA 19380 Phone: 610-431-5000 Fax: 610-738-2356 | |
Boyd C. Myers, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1240 Wrights Lane, West Chester, PA 19380 Phone: 610-431-1210 Fax: 610-594-2625 |